BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29311509)

  • 21. Discovery of novel 7-azaindole derivatives bearing dihydropyridazine moiety as c-Met kinase inhibitors.
    Tang Q; Wang L; Duan Y; Wang W; Huang S; Zhi J; Jia S; Zhu W; Wang P; Luo R; Zheng P
    Eur J Med Chem; 2017 Jun; 133():97-106. PubMed ID: 28384549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 7-Azaindole Analogues as Bioactive Agents and Recent Results.
    Sharma N; Anurag
    Mini Rev Med Chem; 2019; 19(9):727-736. PubMed ID: 30264679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based de novo design and identification of D816V mutant-selective c-KIT inhibitors.
    Park H; Lee S; Lee S; Hong S
    Org Biomol Chem; 2014 Jul; 12(26):4644-55. PubMed ID: 24853767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The azaindole framework in the design of kinase inhibitors.
    Mérour JY; Buron F; Plé K; Bonnet P; Routier S
    Molecules; 2014 Nov; 19(12):19935-79. PubMed ID: 25460315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of potent and selective azaindole-based Rho kinase (ROCK) inhibitors.
    Schirok H; Kast R; Figueroa-Pérez S; Bennabi S; Gnoth MJ; Feurer A; Heckroth H; Thutewohl M; Paulsen H; Knorr A; Hütter J; Lobell M; Münter K; Geiss V; Ehmke H; Lang D; Radtke M; Mittendorf J; Stasch JP
    ChemMedChem; 2008 Dec; 3(12):1893-904. PubMed ID: 18973168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes.
    Eduful BJ; O'Byrne SN; Temme L; Asquith CRM; Liang Y; Picado A; Pilotte JR; Hossain MA; Wells CI; Zuercher WJ; Catta-Preta CMC; Zonzini Ramos P; Santiago AS; Couñago RM; Langendorf CG; Nay K; Oakhill JS; Pulliam TL; Lin C; Awad D; Willson TM; Frigo DE; Scott JW; Drewry DH
    J Med Chem; 2021 Aug; 64(15):10849-10877. PubMed ID: 34264658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Janus kinase 2 inhibitors. Synthesis and characterization of a novel polycyclic azaindole.
    Wang T; Duffy JP; Wang J; Halas S; Salituro FG; Pierce AC; Zuccola HJ; Black JR; Hogan JK; Jepson S; Shlyakter D; Mahajan S; Gu Y; Hoock T; Wood M; Furey BF; Frantz JD; Dauffenbach LM; Germann UA; Fan B; Namchuk M; Bennani YL; Ledeboer MW
    J Med Chem; 2009 Dec; 52(24):7938-41. PubMed ID: 20014869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of C3 substituted chalcone-based derivatives of 7-azaindole as protein kinase inhibitors.
    Qhobosheane MA; Legoabe LJ; Josselin B; Bach S; Ruchaud S; Beteck RM
    Chem Biol Drug Des; 2020 Dec; 96(6):1395-1407. PubMed ID: 32558155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel chemotype of kinase inhibitors: Discovery of 3,4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitors.
    Wang T; Ledeboer MW; Duffy JP; Salituro FG; Pierce AC; Zuccola HJ; Block E; Shlyakter D; Hogan JK; Bennani YL
    Bioorg Med Chem Lett; 2010 Jan; 20(1):153-6. PubMed ID: 19945871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploration of diverse hinge-binding scaffolds for selective Aurora kinase inhibitors.
    Ji Z; Dai Y; Abad-Zapatero C; Albert DH; Bouska JJ; Glaser KB; Marcotte PA; Soni NB; Magoc TJ; Stewart KD; Wei RQ; Davidsen SK; Michaelides MR
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4528-31. PubMed ID: 22727637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploration of 7-azaindole-coumaranone hybrids and their analogues as protein kinase inhibitors.
    Qhobosheane MA; Beteck RM; Baratte B; Robert T; Ruchaud S; Bach S; Legoabe LJ
    Chem Biol Interact; 2021 Jul; 343():109478. PubMed ID: 33905741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited Proteolysis Combined with Stable Isotope Labeling Reveals Conformational Changes in Protein (Pseudo)kinases upon Binding Small Molecules.
    Di Michele M; Stes E; Vandermarliere E; Arora R; Astorga-Wells J; Vandenbussche J; van Heerde E; Zubarev R; Bonnet P; Linders JT; Jacoby E; Brehmer D; Martens L; Gevaert K
    J Proteome Res; 2015 Oct; 14(10):4179-93. PubMed ID: 26293246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragment-based design, synthesis, biological evaluation, and SAR of 1H-benzo[d]imidazol-2-yl)-1H-indazol derivatives as potent PDK1 inhibitors.
    Chen T; Sorna V; Choi S; Call L; Bearss J; Carpenter K; Warner SL; Sharma S; Bearss DJ; Vankayalapati H
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5473-5480. PubMed ID: 29150397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of N-substituted 7-azaindoles as PIM1 kinase inhibitors - Part I.
    Barberis C; Moorcroft N; Arendt C; Levit M; Moreno-Mazza S; Batchelor J; Mechin I; Majid T
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4730-4734. PubMed ID: 28947155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of new pyridazino[4,5-b]indol-4-ones and pyridazin-3(2H)-one analogs as DYRK1A inhibitors.
    Bruel A; Bénéteau R; Chabanne M; Lozach O; Le Guevel R; Ravache M; Bénédetti H; Meijer L; Logé C; Robert JM
    Bioorg Med Chem Lett; 2014 Nov; 24(21):5037-40. PubMed ID: 25248682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Fragment-to-lead Approaches Starting from the 7-azaindole: The Pharmacological Versatility of a Privileged Molecular Fragment.
    Marcos Santos L; da Silveira NJF
    Curr Top Med Chem; 2023; 23(22):2116-2130. PubMed ID: 37461366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approved Small-Molecule ATP-Competitive Kinases Drugs Containing Indole/Azaindole/Oxindole Scaffolds: R&D and Binding Patterns Profiling.
    Zhang H; He F; Gao G; Lu S; Wei Q; Hu H; Wu Z; Fang M; Wang X
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Divergent synthesis of kinase inhibitor derivatives, leading to discovery of selective Gck inhibitors.
    Matsumaru T; Inai M; Ishigami K; Iwamatsu T; Maita H; Otsuguro S; Nomura T; Matsuda A; Ichikawa S; Sakaitani M; Shuto S; Maenaka K; Kan T
    Bioorg Med Chem Lett; 2017 May; 27(10):2144-2147. PubMed ID: 28385506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of fragments for kinase inhibitor design: decoration is key.
    Czodrowski P; Hölzemann G; Barnickel G; Greiner H; Musil D
    J Med Chem; 2015 Jan; 58(1):457-65. PubMed ID: 25437144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinase hinge binding scaffolds and their hydrogen bond patterns.
    Xing L; Klug-Mcleod J; Rai B; Lunney EA
    Bioorg Med Chem; 2015 Oct; 23(19):6520-7. PubMed ID: 26358279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.